β¬80.8 million is provided by Slovenia to maintain key A1 motorway segments near Ljubljana
23 Oct 2025
Slovenia - 12 august 2025For public-interest maintenance work on major motorway sections of the A1 between DomΕΎale and Ljubljana (Zadobrova), including the Ε‘entjakob and Sneberje interchanges, the Motorway Company in the Republic of Slovenia (DARS d.d.) has awarded a β¬80.79 million contract. Two of Slovenia's top infrastructure and construction firms, CGP d.d. and POMGRAD d.d., make up the winning consortium. The agreement, which was signed on August 12, 2025, intends to guarantee better-maintained, safer, and more resilient motorway infrastructure in the busiest corridor in the country.Overview of the Contract"VzdrΕΎevalna dela v javno korist za cesto in objekte na odsekih AC A1/0046/0646 DomΕΎale - entjakob, A1/0047/0647 entjakob-LJ (Zadobrova), 0145 prikljuΔek LJ entjakob in 0189 prikljuΔek LJ Sneberje" covers necessary engineering and construction maintenance on the road surface and related structures.The project will take 50 months to complete and will cost β¬80,786,656.61 (VAT excluded), which is much less than the original β¬93.55 million estimate and reflects a competitive procurement process.Work ScopeIncluded in the contract are: restoration of the A1 motorway's bridges and road surfaces. upkeep of traffic control, safety barriers, and drainage systems. The motorway intersections at Ljubljana Ε entjakob and Ljubljana Sneberje have been upgraded. Enhancements in safety and the environment to guarantee adherence to national and EU regulations. The A1, Slovenia's main north-south transportation route that connects Ε entilj, Ljubljana, and Koper, will undergo these repairs as part of DARS's long-term maintenance plan.Results and the Tender ProcessThree tenders, all submitted electronically, were drawn from the open procedure under Directive 2014/24/EU. The winner was chosen based on the lowest price criterion (100%) in this case.The lowest allowable bid, β¬80.79 million, was made by the CGP-POMGRAD consortium. Competitors then made offers as high as β¬84.49 million. Upon verification, one bid was deemed inadmissible.Important Contract Information: The Republic of Slovenia's Motorway Company, DARS d.d., is the contracting authority. Value of Contract: β¬80,786,656.61 (VAT excluded) 50 months is the estimated duration. Award Date: August 12, 2025 Financed by the national budget (not EU funds) Type of Procedure: Open procedure Lowest price is the award criterion. Winning Team: One of Slovenia's biggest infrastructure contractors, CGP d.d. (Leader) is headquartered in Novo Mesto and specialises in road construction, civil engineering, and maintenance. POMGRAD, d.d. The company, which has its headquarters in Murska Sobota, has extensive experience with road infrastructure, bridges, and large-scale civil works. To increase productivity and local economic involvement, the consortium will subcontract work totalling about β¬1.98 million to specialised local companies.Strategic SignificanceThe mainstay of Slovenia's transport network, the A1 motorway connects the country's capital, Ljubljana, to important business centres and the Adriatic coast. Over 60,000 daily commuters in the Ljubljana region benefit from uninterrupted mobility, logistical support, and increased safety thanks to regular maintenance investments.Slovenia's strategic emphasis on long-term asset management and sustainable infrastructure is emphasised by DARS's dedication to ongoing improvements and preventive maintenance.To sum up:Slovenia's proactive approach to motorway management is further supported by this β¬80.8 million maintenance contract. The A1 section from DomΕΎale to Ljubljana (Zadobrova) is scheduled for major renewal, with CGP and POMGRAD spearheading the project. This will enhance safety, driving comfort, and infrastructure resilience along one of the nation's most important transportation corridors. Tags: #Slovenia #RoadMaintenance #A1Motorway #PublicProcurement #InfrastructureDevelopment #HighwayProjects #DARS #CGP #POMGRAD #TransportInfrastructure #ConstructionNews #TenderResults, #CivilEngineering
Read More
Ljubljanaβs Oncology Institute Awards β¬178 Million Framework Agreement for Medicine Supply to Strengthen Cancer Care in Slovenia
15 Oct 2025
The Oncological Institute of Ljubljana, Sloveniaβs leading cancer treatment and research center, has awarded a landmark β¬178.04 million framework agreement for the purchase and supply of pharmaceutical products. The multi-supplier agreement, finalized between late August and early September 2025, aims to ensure a reliable supply of critical medicines - including antitumor agents and biological drugs - for the next 30 months.Contract Overview Published in the Official Gazette S 177/2025 on 16 September 2025, this restricted procedure covers the procurement of pharmaceutical products (CPV 33600000) for use at the Oncological Institute of Ljubljana. The agreement, valued at β¬178.04 million (excluding VAT), runs from 1 October 2025 to 31 March 2028, ensuring a consistent and long-term supply chain for the instituteβs medical operations. The framework agreement, executed under Directive 2014/24/EU, allows multiple qualified suppliers to provide various medicines in compliance with national regulatory standards. It is not financed by EU funds and not covered by the GPA, indicating a domestic public procurement focus. Entities and Awardees The Oncological Institute of Ljubljana, a public health authority under Slovenian law, serves as the contracting authority. Following a competitive process that attracted 19 tenders, 21 pharmaceutical and medical supply companies were selected to participate in the framework agreement. Key awardees include: Institute of the Republic of Slovenia for Transfusion Medicine Salus d.o.o. - A leading Slovenian wholesaler of pharmaceutical and medical products Sanolabor d.d. - A long-established supplier of laboratory and hospital equipment Medis d.o.o., Roche d.o.o., Bayer d.o.o., Kemofarmacija d.d., among others Most of the winning companies are based in Ljubljana and Central Slovenia, reflecting the regionβs strong pharmaceutical distribution network. Significance and Impact This large-scale procurement marks a strategic milestone in Sloveniaβs public health sector. By securing a multi-year, multi-supplier framework, the Oncology Institute ensures uninterrupted access to life-saving medicines and enhances its capacity to deliver advanced cancer treatment. The frameworkβs structure, which allows for reopening of competition among suppliers, promotes transparency, cost-effectiveness, and flexibility in responding to evolving therapeutic needs. It also supports domestic pharmaceutical enterprises, many of which are micro and small businesses, reinforcing Sloveniaβs healthcare supply resilience. Technical and Legal Criteria To qualify, bidders were required to hold valid licenses for wholesale trade in medicinal products, issued by the Public Agency for Medicinal Products and Medical Devices. The selection in Phase I focused on compliance, regulatory certification, and proof of professional competence in pharmaceutical distribution. Conclusion The Oncology Instituteβs β¬178 million investment represents a robust commitment to strengthening Sloveniaβs oncology infrastructure and pharmaceutical security. As the framework agreement moves into implementation, patients across the country stand to benefit from enhanced access to high-quality and innovative cancer therapies - a step that underscores Sloveniaβs dedication to public health and medical excellence. Tags: #Slovenia #ProcurementNews #ContractAward #OncologyInstituteLjubljana #PharmaceuticalProducts #MedicineSupply #HealthcareContracts #TenderResults #PublicProcurement #GovernmentContracts #SloveniaHealthcare #Tenders
Read More